Atara Biotherapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Atara Biotherapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Atara Biotherapeutics Inc Strategy Report
- Understand Atara Biotherapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Atara Biotherapeutics Inc (Atara) is a T-cell immunotherapy company that develops innovative treatments for autoimmune diseases including cancer, and for various viral diseases. The company bioengineers allogeneic T-cells of from healthy donors and facilitates rapid delivery from inventory to patients without any pretreatment. Its T-cell immunotherapies identify and eradicate cancerous cells without affecting healthy cells.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Atara Biotherapeutics focuses on conducting R&D activities to further develop its pipeline candidates in various phases of clinical trials. In FY2022, Atara incurred research and development expenses of US$272.5 million which decreased 3.4% YoY. The company owns 33 patent families that consist of 330 issued patents and patent applications that span compositions of matter and associated methods, including methods of treatment. Its patents are scheduled to expire between 2023 and 2042.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer